Wordt geladen...
Walking impairment in patients with multiple sclerosis – a new therapeutic approach and clinical potential of dalfampridine extended release tablets
Walking impairment is a clinical hallmark of multiple sclerosis (MS) that has been under-recognized as a therapeutic target for pharmacologic intervention. The development and approval of dalfampridine extended release tablets (dalfampridine-ER; known as prolonged-, modified, or sustained-release fa...
Bewaard in:
| Gepubliceerd in: | Degener Neurol Neuromuscul Dis |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065578/ https://ncbi.nlm.nih.gov/pubmed/30890878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S19839 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|